C09972005 / invoice 10000

Species:CANINE
Breed:Poodle - Toy Cross
Age (years):6
Diagnosis or signs:Skin condition
Consult notes
HISTORYPresenting for: Murphy presented for ongoing pruritus and secondary skin infections, with continued itching despite previous cytopoint 2 months agoHistorical Conditions: Previous Malassezia infection on feet treated, ears were fairly clean at last visit, received Cytopoint injection 2 months ago (10mg) at same time as vaccinesSkin: Ongoing pruritus affecting feet and other areas of body, licking and chewing at feet, previous crusty discharge between toesCurrent Meds: Cortavance (bottle with syringes for ears), Malaseb washes for feet every 2nd day, cytopoint last 2 months agoEXAMBehavioural: Nervous during examination, watching veterinarian closelyEars: Clean bilaterally, no discharge or inflammation notedIntegumentary: Feet looking significantly improved compared to previous visit, minimal crusty discharge between digits, no significant erythema or swelling noted between toesDiagnostics: Cytology from feet - very few Malassezia organisms present, some bacteria consistent with normal flora, no overgrowth of concern. Secondary infections appear under controlear cytology: AWNLASSESSMENTAllergic dermatitis with secondary Malassezia infection - secondary infections now under control but underlying pruritus persists, likely requiring ongoing allergy management. Cytopoint effects have worn off after 2 monthsPLANNew Meds/Tx:- Cytopoint injection administered today for allergy control- Cortavance spray can be used on feet 1-2 sprays per foot once daily if needed for localised inflammation and itchingAdditional Discussion:- Malaseb foot washes can be reduced in frequency as Malassezia infection is now controlled- If current Cytopoint dose insufficient, can consider increasing dose or alternative daily oral allergy medications- Monitor for recurrence of crusty discharge between toes, resume more frequent washing if needed- Continue current ear treatment protocol as ears remain clean

Animal clinical history (3 most recent)

2026-03-02T00:00:00Z 10:00?am
HISTORYPresenting for: Murphy presented for ongoing pruritus and secondary skin infections, with continued itching despite previous cytopoint 2 months agoHistorical Conditions: Previous Malassezia infection on feet treated, ears were fairly clean at last visit, received Cytopoint injection 2 months ago (10mg) at same time as vaccinesSkin: Ongoing pruritus affecting feet and other areas of body, licking and chewing at feet, previous crusty discharge between toesCurrent Meds: Cortavance (bottle with syringes for ears), Malaseb washes for feet every 2nd day, cytopoint last 2 months agoEXAMBehavioural: Nervous during examination, watching veterinarian closelyEars: Clean bilaterally, no discharge or inflammation notedIntegumentary: Feet looking significantly improved compared to previous visit, minimal crusty discharge between digits, no significant erythema or swelling noted between toesDiagnostics: Cytology from feet - very few Malassezia organisms present, some bacteria consistent with normal flora, no overgrowth of concern. Secondary infections appear under controlear cytology: AWNLASSESSMENTAllergic dermatitis with secondary Malassezia infection - secondary infections now under control but underlying pruritus persists, likely requiring ongoing allergy management. Cytopoint effects have worn off after 2 monthsPLANNew Meds/Tx:- Cytopoint injection administered today for allergy control- Cortavance spray can be used on feet 1-2 sprays per foot once daily if needed for localised inflammation and itchingAdditional Discussion:- Malaseb foot washes can be reduced in frequency as Malassezia infection is now controlled- If current Cytopoint dose insufficient, can consider increasing dose or alternative daily oral allergy medications- Monitor for recurrence of crusty discharge between toes, resume more frequent washing if needed- Continue current ear treatment protocol as ears remain clean    Vital Signs    Weight: 9.3;       

Previous claim history (18)

DateClaim #Diagnosis
2026-02-19C09925216HYPERSENSITIVITY (ALLERGIC) SKIN DISORDER
2026-01-12C09744247HYPERSENSITIVITY (ALLERGIC) SKIN DISORDER
2025-12-20C09655029OTITIS EXTERNA
2025-12-11C09610057OTITIS EXTERNA
2024-03-05C6956648LAMENESS LF
2024-02-21C6905149LAMENESS LF
2024-01-12C6749772HEARTWORM CONTROL
2024-01-12C6749772VACCINATIONS OR HEALTH CHECKS
2023-11-07C6507347HYPERSENSITIVITY (ALLERGIC) SKIN DISORDER
2023-11-07C6507347INAPPETANCE
2023-04-24C5828055COUGHING - PRESENTING COMPLAINT
2023-04-18C5805137ATOPY
2022-11-25C5472186ATOPY
2022-11-02C5251236ANAL SAC ABSCESS
2022-10-28C5244622ANAL SAC ABSCESS
2022-08-04C4985177MISCELLANEOUS CONDITIONS
2021-12-31C4360534HEARTWORM CONTROL
2021-12-31C4360534VACCINATIONS OR HEALTH CHECKS

Line items(lines with upstream diagnosis are skipped by the model)

LinetstarcAmountDateUpstream diagnosis
10000tstarc_consultation-revisit72.002026-03-02
20000tstarc_skin_medication_-_cytopoint172.302026-03-02
30000tstarc_diagnostic_test_-_cytology70.402026-03-02

UPM+

  • DG02339HYPERSENSITIVITY DISORDER (ALLERGY)DSTP_skin_-_allergic_disorder

Variant (sleepy_king)

HYPERSENSITIVITY DISORDER (ALLERGY)
DSTP_skin_-_allergic_disorder
Conf: 0.760
Threshold: 0.38
Above:
Correct?